PRECIGEN, INC.·4

May 27, 8:15 PM ET

Lehr Donald P. 4

4 · PRECIGEN, INC. · Filed May 27, 2026

Research Summary

AI-generated summary of this filing

Updated

Precigen (PGEN) CLO Donald Lehr Converts 62,500 RSUs

What Happened

  • Donald P. Lehr, Chief Legal Officer of Precigen (PGEN), reported the conversion/exercise of 62,500 restricted stock units (RSUs) into 62,500 shares on May 23, 2026. The filing also reports a simultaneous disposition of 62,500 shares at $0, resulting in no net shares delivered to Lehr according to the report.
  • The filing treats these entries as derivative transactions (transaction code M). No cash proceeds or dollar value are reported for the acquisition; the reported disposition shows $0 proceeds.

Key Details

  • Transaction date: May 23, 2026; Filing date (Form 4): May 27, 2026.
  • Reported transactions: Acquired 62,500 shares (conversion of RSUs), Disposed 62,500 shares at $0. Transaction code M = exercise/conversion of a derivative/security.
  • Shares owned after transaction: Not specified in the provided filing excerpt.
  • Footnotes from the filing:
    • F1: Each RSU represents a contingent right to receive one share of Precigen common stock.
    • F2: These 62,500 shares represent 50% of the RSUs granted on June 26, 2025 that vested on May 23, 2026; the remaining RSUs will vest in equal quarterly installments over the next three years.

Context

  • This was not an open-market buy or sell. The entries reflect RSU vesting and conversion into shares and a simultaneous reported disposition of the same number of shares (reported at $0), leaving no net share increase per the filing. Such filings commonly reflect vesting/settlement mechanics rather than a traded market view; the filing gives no indication of a market-direction signal.

Insider Transaction Report

Form 4
Period: 2026-05-23
Lehr Donald P.
Chief Legal Officer
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-05-23+62,500784,592 total
  • Exercise/Conversion

    Restricted Stock Units

    [F1][F2]
    2026-05-2362,50062,500 total
    Common Stock (62,500 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.
  • [F2]Represents 50% of the RSUs granted on June 26, 2025 that vested on May 23, 2026. The remaining RSUs will vest in equal quarterly installments for three years thereafter.
Signature
/s/ Donald P. Lehr|2026-05-27

Documents

1 file
  • 4
    ownership.xmlPrimary

    FORM 4